Nomura Holdings
LSTA icon

Nomura Holdings’s Lisata Therapeutics LSTA Stock Holding History

Nomura Holdings’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-142
Closed -$16K – 1458
2016
Q1 		$16K Sell
142
-108
-43% -$10.6K ﹤0.01% 1496
2015
Q4 		$40K Buy
+250
New +$45.9K ﹤0.01% 1771
2013
Q4 		– Sell
-70
Closed -$90K – 2171
2013
Q3 		$90K Buy
70
+8
+13% +$8.88K ﹤0.01% 2081
2013
Q2 		$51K Buy
+62
New +$54.4K ﹤0.01% 2072

Other funds holding LSTA

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Nomura Holdings's LSTA Position: Q2 2016 in Review

Nomura Holdings sold out of Lisata Therapeutics (LSTA) in Q2 2016, closing a stake of 142 shares — an estimated $16K sold.

Nomura Holdings first reported a position in LSTA in Q2 2013 and held it in 4 quarters. The position peaked at $90K in Q3 2013. 43 funds tracked by Wall St. Rank hold LSTA as of Q2 2016.

  • Nomura Holdings reported no remaining Lisata Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Nomura Holdings sold 142 Lisata Therapeutics shares in Q2 2016, an estimated $16K.
  • Nomura Holdings first reported a position in Lisata Therapeutics in Q2 2013 and held it in 4 quarters.
  • Nomura Holdings's Lisata Therapeutics position peaked at $90K in Q3 2013.
  • 43 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2016.

Based on Nomura Holdings's 13F filing for Q2 2016, filed 15 Aug 2016.